Skip to content

Activation of Brown Adipose Tissue in Old and Young Individuals

Activation of Brown Adipose Tissue in Old and Young Individuals - Activation of Brown Adipose Tissue and Age

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39994
Enrollment
24
Registered
2013-02-21
Start date
2013-04-09
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity Overweight and age

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male Caucasian Origin 18-65 years old BMI range 19-27kg/m2 Subjects should be able and willing to give informed consent

Exclusion criteria

Exclusion criteria: Renal failure (creatinine >135 mmol/L) Daily use of prescription medicine Prior participation in a research protocol involving radiation exposure in the last 2 years

Design outcomes

Primary

MeasureTime frame
Difference in semi quantitative uptake value of the tracer MIBG visualised with SPECT-CT in BAT (younger versus older individuals).

Secondary

MeasureTime frame
The correlation between semi-quantitative uptake of MIBG and SUV of FDG in young and older individuals will be calculated with a Pearson correlation coefficient. P-values for the difference in resting energy expenditure during thermoneutral conditions and during mild cold-exposure will be calculated with independent sample t-tests. Subsequently, the correlation between this difference in resting energy expenditure and the sympathetic stimulation of BAT as assessed with MIBG (and with metabolic BAT activity as assessed with FDG), will be calculated with a Pearson correlation coefficient. The correlation between insulin resistance in different age groups, and semi-quantitative uptake of MIBG, or SUV of FDG will be calculated with a Pearson correlation coefficient In view of the limited size of the study, no multivariate analyses will be performed.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)